163 related articles for article (PubMed ID: 36889900)
1. Proposed triggers for retiring a living systematic review.
Murad MH; Wang Z; Chu H; Lin L; El Mikati IK; Khabsa J; Akl EA; Nieuwlaat R; Schuenemann HJ; Riaz IB
BMJ Evid Based Med; 2023 Oct; 28(5):348-352. PubMed ID: 36889900
[TBL] [Abstract][Full Text] [Related]
2. Methods and guidance on conducting, reporting, publishing and appraising living systematic reviews: a scoping review protocol.
Iannizzi C; Akl EA; Kahale LA; Dorando E; Mosunmola Aminat A; Barker JM; McKenzie JE; Haddaway NR; Piechotta V; Skoetz N
F1000Res; 2021; 10():802. PubMed ID: 35186269
[No Abstract] [Full Text] [Related]
3. Methods and guidance on conducting, reporting, publishing, and appraising living systematic reviews: a scoping review.
Iannizzi C; Akl EA; Anslinger E; Weibel S; Kahale LA; Aminat AM; Piechotta V; Skoetz N
Syst Rev; 2023 Dec; 12(1):238. PubMed ID: 38098023
[TBL] [Abstract][Full Text] [Related]
4. Experience report of two living systematic Cochrane reviews on COVID-19.
Wagner C; Hirsch C; Siemens W; Kapp P; Iannizzi C
Z Evid Fortbild Qual Gesundhwes; 2024 Mar; 184():90-95. PubMed ID: 38220533
[TBL] [Abstract][Full Text] [Related]
5. Methods of conduct and reporting of living systematic reviews: a protocol for a living methodological survey.
Khamis AM; Kahale LA; Pardo-Hernandez H; Schünemann HJ; Akl EA
F1000Res; 2019; 8():221. PubMed ID: 31231512
[No Abstract] [Full Text] [Related]
6. Needs and feasibility of living systematic reviews (LSRs): Experience from LSRs on COVID-19 vaccine effectiveness.
Külper-Schiek W; Thielemann I; Pilic A; Meerpohl JJ; Siemens W; Vygen-Bonnet S; Koch J; Harder T; Piechotta V
Z Evid Fortbild Qual Gesundhwes; 2024 May; 186():86-91. PubMed ID: 38519357
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and acceptability of living systematic reviews: results from a mixed-methods evaluation.
Millard T; Synnot A; Elliott J; Green S; McDonald S; Turner T
Syst Rev; 2019 Dec; 8(1):325. PubMed ID: 31837703
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of Living Systematic Review for COVID-19.
Chen Z; Luo J; Li S; Xu P; Zeng L; Yu Q; Zhang L
Clin Epidemiol; 2022; 14():925-935. PubMed ID: 35958161
[TBL] [Abstract][Full Text] [Related]
9. Optimizing process and methods for a living systematic review: 30 search updates and three review updates later.
Butler AR; Hartmann-Boyce J; Livingstone-Banks J; Turner T; Lindson N
J Clin Epidemiol; 2024 Feb; 166():111231. PubMed ID: 38043829
[TBL] [Abstract][Full Text] [Related]
10. Conceptualizing the reporting of living systematic reviews.
Khabsa J; Chang S; McKenzie JE; Barker JM; Boutron I; Kahale LA; Page MJ; Skoetz N; Akl EA
J Clin Epidemiol; 2023 Apr; 156():113-118. PubMed ID: 36736707
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Extension of the PRISMA 2020 statement for living systematic reviews (LSRs): protocol.
Kahale LA; Piechotta V; McKenzie JE; Dorando E; Iannizzi C; Barker JM; Page MJ; Skoetz N; Akl EA
F1000Res; 2022; 11():109. PubMed ID: 38813137
[No Abstract] [Full Text] [Related]
13. Living Systematic Reviews.
Simmonds M; Elliott JH; Synnot A; Turner T
Methods Mol Biol; 2022; 2345():121-134. PubMed ID: 34550587
[TBL] [Abstract][Full Text] [Related]
14. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
[TBL] [Abstract][Full Text] [Related]
16. Living systematic review: 1. Introduction-the why, what, when, and how.
Elliott JH; Synnot A; Turner T; Simmonds M; Akl EA; McDonald S; Salanti G; Meerpohl J; MacLehose H; Hilton J; Tovey D; Shemilt I; Thomas J;
J Clin Epidemiol; 2017 Nov; 91():23-30. PubMed ID: 28912002
[TBL] [Abstract][Full Text] [Related]
17. The life and death of living systematic reviews: a methodological survey.
Akl EA; El Khoury R; Khamis AM; El Mikati IK; Pardo-Hernandez H; Farran S; Ibrahim R; Khamis M; Hneiny L; Schunemann HJ; Kahale LA
J Clin Epidemiol; 2023 Apr; 156():11-21. PubMed ID: 36764466
[TBL] [Abstract][Full Text] [Related]
18. Methodological challenges for living systematic reviews conducted during the COVID-19 pandemic: A concept paper.
Iannizzi C; Dorando E; Burns J; Weibel S; Dooley C; Wakeford H; Estcourt LJ; Skoetz N; Piechotta V
J Clin Epidemiol; 2022 Jan; 141():82-89. PubMed ID: 34525406
[TBL] [Abstract][Full Text] [Related]
19. Methodological quality and reporting quality of COVID-19 living systematic review: a cross-sectional study.
Luo J; Chen Z; Liu D; Li H; He S; Zeng L; Yang M; Liu Z; Xiao X; Zhang L
BMC Med Res Methodol; 2023 Jul; 23(1):175. PubMed ID: 37525117
[TBL] [Abstract][Full Text] [Related]
20. Pragmatic and open science-based solution to a current problem in the reporting of living systematic reviews.
Metzendorf MI; Weibel S; Reis S; McDonald S
BMJ Evid Based Med; 2023 Aug; 28(4):267-272. PubMed ID: 36351782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
